18F-FDG PET和PET/CT评估肿瘤新辅助化疗效果的应用进展
网络出版日期: 2010-09-27
基金资助
上海市重点学科建设项目(S30203)
Progress of application of 18F-FDG PET and PET/CT in assessment of response of tumor to neoadjuvant chemotherapy
Online published: 2010-09-27
Supported by
Shanghai Leading Academic Discipline Project, S30203
张 敏 . 18F-FDG PET和PET/CT评估肿瘤新辅助化疗效果的应用进展[J]. 上海交通大学学报(医学版), 2010 , 30(9) : 1072 . DOI: 10.3969/j.issn.1674-8115.2010.09.013
Neoadjuvant chemotherapy is increasingly widely used in the treatment of cancer, and 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) and PET/CT play a role in the early assessment of response to neoadjuvant chemotherapy, including tumor restaging, drug selection and prognosis prediction, which facilitate the design of therapeutic regimen and reduction of ineffective therapy.The progress of application of 18F-FDG PET and PET/CT in the assessment of response of tumor to neoadjuvant chemotherapy is reviewed in this paper.
/
〈 |
|
〉 |